AGP Executive Report
Last update: 12 hours agoBiopharma Deal Shock: Hengrui Pharma surged after signing a $15.2B global alliance with Bristol Myers Squibb to advance 13 early-stage oncology, hematology and immunology programs, with $600M upfront and potential milestones; rights split so Hengrui keeps China/HK/Macau while BMS takes ex-China territories. Macau Tech & Gaming Spotlight: G2E Asia + Asian IR Expo opens today at The Venetian Macao, drawing 8,000+ professionals across 90+ regions and putting digital innovation (including AI) front and center for gaming and integrated resorts. Macau Business Pulse: Galaxy Entertainment posted Q1 2026 results with adjusted EBITDA of $3.6B (+21% YoY), while reporting Macau visitation strength and noting quarter-to-quarter luck effects. Public Health Alert: Macau’s mosquito index jumped in April, raising dengue and chikungunya risk as authorities urge bite prevention. Energy Build-Out: CGN began construction on Unit 4 of the Taipingling Hualong One project in Guangdong’s GBA, extending the region’s nuclear expansion.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
